Recently published in the Journal of Medical Genetics* results of a case-control study spearheaded by VHIO’s Judith Balmaña show that…
Hereditary Cancer Genetics Group
Barcelona, August 02, 2021. The BRCA1 and BRCA2 genes are crucial actors in the DNA damage response and repair pathway;…
ASCO Plenary: PARPi prevents disease recurrence in BRCA-mutated high-risk, early stage breast cancer
Full results from the OlympiA Phase III, multicenter trial promise to extend the use of PARPi olaparib as adjuvant therapy…
In parallel with the European Society for Medical Oncology’s (ESMO) publication of its 2025 Vision, which builds on the core…
